Stephen Kevin Burley

Sgx Pharmaceuticals, Inc.

$8,295,708

Attributed

$8,295,708

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $9.6M · FY2005–09

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

Funding mix

By agency

NIH$54,469,546 · 4

By mechanism

U54$46,173,838 · 1

P50$8,287,708 · 1

R13$8,000 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Escherichia Coli”

David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
Scott J Hultgren · Washington University$41,419,179
John L Markley · University Of Wisconsin Madison$37,032,573
Wilhelmus G. J. Hol · University Of Washington$31,124,692
Vanessa Sperandio · University Of Wisconsin-Madison$27,468,669
Peter D Karp · Sri International$27,278,650

Research focus

Escherichia ColiFunctional /Structural GenomicsData CollectionX Ray CrystallographyProtein Structure FunctionBiotechnologySaccharomyces CerevisiaeMass SpectrometryMolecular CloningMolecular Biology Information SystemProtein StructureComputer Program /SoftwareComputer System Design /EvaluationCooperative StudyHigh Throughput TechnologyInformation DisseminationGenetic LibraryBacterial ProteinsData Collection Methodology /EvaluationBiomedical AutomationHigh Performance Liquid ChromatographyModel Design /DevelopmentInternetProtein Purification